会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • 피부미백 및 PPAR 활성을 갖는 신규 화합물 및 이의 의학적 용도
    • 具有皮肤白化和PPAR活性的新化合物及其医疗用途
    • KR101292478B1
    • 2013-07-31
    • KR1020130013616
    • 2013-02-06
    • 부산대학교 산학협력단
    • 정해영문형룡이혜진박지영박윤정박진남박준환정유리안혜진
    • C07D277/66C07D513/04A61K31/428A61P3/00
    • PURPOSE: A novel compound with whitening effect and peroxisome proliferator-activated receptor (PPAR) activity is provided to ensure skin whitening activity by suppressing tyrosinase, and to be used in a pharmaceutical composition or a cosmetic product for skin whitening, and as a pharmaceutical composition or a health functional food for preventing and treating obesity, metabolic diseases, or cardiovascular diseases. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound of chemical formula 1 as an active ingredient. The compound is selected from the group consisting of 2- (2,4-dihydroxyphenyl)-5,6- (methylenedioxy)-benzothiazole, 2- (3-methoxy-4-hydroxyphenyl)-5,6- (methylenedioxy)-benzothiazole, 4- (6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)benzene-1,3-diol, 5- (6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)-2-methoxyphenol, and bromo-4- (6,7-dihydro-5H-indeno[5,6-d]thiazol-2-yl)phenol. A pharmaceutical composition for preventing or treating one disease selected among obesity, metabolic diseases, and cardiovascular diseases contains the compound of chemical formula 1 as an active ingredient, and is regulated by PPAR activity. The PPAR is PPAR alpha or PPAR gamma.
    • 目的:提供一种具有增白效果和过氧化物酶体增殖物激活受体(PPAR)活性的新型化合物,以通过抑制酪氨酸酶来确保皮肤美白活性,并用于药物组合物或化妆品中用于皮肤美白,以及作为药物组合物 或用于预防和治疗肥胖症,代谢疾病或心血管疾病的健康功能食品。 构成:化合物由化学式1表示。皮肤美白组合物含有化学式1的化合物作为活性成分。 该化合物选自2-(2,4-二羟基苯基)-5,6-(亚甲二氧基) - 苯并噻唑,2-(3-甲氧基-4-羟基苯基)-5,6-(亚甲二氧基) - 苯并噻唑 ,4-(6,7-二氢-5H-茚并[5,1-d]噻唑-2-基)苯-1,3-二醇,5-(6,7-二氢-5H-茚并[5,6 d]噻唑-2-基)-2-甲氧基苯酚和溴代-4-(6,7-二氢-5H-茚并[5,1-d]噻唑-2-基)苯酚。 用于预防或治疗选自肥胖,代谢疾病和心血管疾病的一种疾病的药物组合物含有化学式1的化合物作为活性成分,并受PPAR活性调节。 PPAR是PPARα或PPARγ。